Dan Kaufman

Credentials: · · · · ·

History

Human iPSC-Derived Natural Killer Cells Engineered with Chimeric Antigen Receptors Enhance Anti-tumor Activity
Cell stem cell · 2018 · Last of 4 authors · Corresponding · 834 citations
Hematopoietic colony-forming cells derived from human embryonic stem cells
Proceedings of the National Academy of Sciences of the United States of America · 2001 · First of 5 authors · 651 citations
Multilineage differentiation from human embryonic stem cell lines
Review · Stem Cells · 2001 · 631 citations

Cancer Therapy by Targeting Innate Immune Cells in vivo Using Novel Virus-Like Particles
National Cancer Institute · R21
Contact PI · $409.6K · University of California, San Diego
2025–2027
A Rational Systematic Approach to Find Combinations of Pharmacologic and Immune Therapies That Target Identifiable Oncogenic States
National Cancer Institute · U01
PI · $5.1M · University of California, San Diego
2017–2023
Identification of Novel Regulators of Natural Killer Cell Activity
National Cancer Institute · R21
Contact PI · $402.2K · University of California, San Diego
2020–2022
Expression of Recombinant Fc Receptors by Engineered NK Cells to Enhance Cancer Cell Killing
National Cancer Institute · R01
PI · $2.2M · University of Minnesota
2016–2021